Study discloses clinical-relevant intertumoral heterogeneity of NSCLCs driven by MET exon 14 skipping

A study presented today at the IASLC World Conference on Lung Cancer 2022 in Vienna disclosed the clinical-relevant intertumoral heterogeneity of non-small cell lung cancer (NSCLC) driven by MET exon 14 skipping.

source https://medicalxpress.com/news/2022-08-discloses-clinical-relevant-intertumoral-heterogeneity-nsclcs.html